US Stock MarketDetailed Quotes
OCGN Ocugen
- 0.9222
- +0.0148+1.63%
Close Nov 25 16:00 ET
- 0.9199
- -0.0023-0.25%
Post 18:16 ET
268.66MMarket Cap-4853P/E (TTM)
0.9700High0.9150Low4.76MVolume0.9185Open0.9074Pre Close4.46MTurnover1.66%Turnover RatioLossP/E (Static)291.32MShares2.105052wk High6.63P/B265.01MFloat Cap0.360052wk Low--Dividend TTM287.37MShs Float778.1999Historical High--Div YieldTTM6.06%Amplitude0.1700Historical Low0.9360Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Ocugen Stock Forum
Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate Ocu410St for Treatment of Abca4-Associated Retinopathies Including Stargardt Disease
Ocugen Announces Compelling Preliminary Data for Ocu410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
No comment yet